Hyloris Therapeutics
The computed 12-month bankruptcy probability of Hyloris Therapeutics is 1.0% (low). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 1 yrs |
| Locations | 1 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| NACE primary | Vervaardiging van geneesmiddelen(21201) |
| Legal form | Public limited company(014) |
| Incorporation | 02-07-2025 |
| Status | Active |
| Postal code | 4000 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62042B0366/00B003 | Wallonia | 1.9 ha | - | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
26-09-2025 Christophe Pelzer appointed as statutory auditor
- Christophe Pelzer, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Christophe Pelzer",
"address": null,
"birth_date": null,
"profession": "commissaire agr\u00E9\u00E9",
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": "0431.088.289",
"name": "BDO R\u00E9viseurs d\u0027Entreprises SRL",
"address": "Da Vincilaan 9, Bus 6, 1935 Zaventem",
"country": "BE",
"legal_form": "SRL"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "Nomination de BDO Bedrijfsrevisoren BV | BDO R\u00E9viseurs d\u0027Entreprises SRL en tant que commissaire de la Soci\u00E9t\u00E9",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": 3
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": "Christophe Pelzer",
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Li\u00E8ge",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-09-26",
"filing_date": "2025-07-07",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2025-07-07",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "1025.029.385",
"name_full": "Hyloris Therapeutics",
"legal_form": "SA",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Th\u00E9otime Liesenborghs",
"org_rep_person_name": null,
"person_role_at_subject": "Mandataire"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}| Legal nameFR | Hyloris Therapeutics |